Tadalafil Tablet, Film Coated
Product Images NDC 50090-7314

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50090-7314). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907314)

Label Image (Lbl500907314)
This text appears to showcase information about a product. It includes details such as "5 MG" contents and quantity ("90 TABLETS"). The text also mentions the product being available at a specific temperature of "77 DEGREES". The product code or label seems to be "1mc, zotpe" and "T ebr0-0 FRoacaFiL".*
FDA Label Image

Chemical Structure (Tadalafil 1)

FDA Label Image

Tadalafil-tablets-figure-1 (Tadalafil 2)

Tadalafil-tablets-figure-1 (Tadalafil 2)
This text provides data on the difference in blood pressure (mmHg) between Tadalafil and Placebo. It includes measurements for standing systolic and diastolic blood pressure, as well as supine systolic and diastolic blood pressure at various time points.*
FDA Label Image

Tadalafil-tablets-figure-2 (Tadalafil 3)

Tadalafil-tablets-figure-2 (Tadalafil 3)
This is not-available.*
FDA Label Image

Tadalafil-tablets-figure-3 (Tadalafil 4)

Tadalafil-tablets-figure-3 (Tadalafil 4)
This is a table showing the systolic blood pressure (BP) at different time points after the administration of different doses of tadalafil and doxazosin. The table includes the comparison between 20 mg tadalafil and placebo at different time points along with 8 mg daily doxazosin.*
FDA Label Image

Tadalafil-tablets-figure-4 (Tadalafil 5)

Tadalafil-tablets-figure-4 (Tadalafil 5)
This description provides a comparison of plasma tadalafil concentrations (in ug/L) at various time points after different dosages and administration schedules. It showcases the levels achieved after a single 20-mg dose, a single 5-mg dose, and once-daily 5-mg doses over 5 days. The time points include measurements at 12, 24, 36, 48, 60, 72, 84, 96, 108, and 120 hours.*
FDA Label Image

Table 5 (Tadalafil 6)

FDA Label Image

Table 6 (Tadalafil 7)

FDA Label Image

Tadalafil-tablets-figure-7 (Tadalafil 8)

FDA Label Image

Image 8 (Tadalafil 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.